These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32115297)

  • 1. Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands.
    Naber SK; Bruijning-Verhagen PCJL; de Hoog MLA; van Giessen A
    Vaccine; 2020 Apr; 38(17):3387-3396. PubMed ID: 32115297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.
    de Boer PT; Backer JA; van Hoek AJ; Wallinga J
    BMC Med; 2020 Jan; 18(1):11. PubMed ID: 31931789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S.
    Smith KJ; Raviotta JM; DePasse JV; Brown ST; Shim E; Patricia Nowalk M; Zimmerman RK
    Am J Prev Med; 2016 May; 50(5):600-608. PubMed ID: 26868283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
    Brydak L; Roiz J; Faivre P; Reygrobellet C
    Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
    Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
    Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program.
    Zeevat F; Crépey P; Dolk FCK; Postma AJ; Breeveld-Dwarkasing VNA; Postma MJ
    Value Health; 2021 Jan; 24(1):3-10. PubMed ID: 33431150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
    Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
    de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
    Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness of potential government fully-funded influenza vaccination in population with diabetes in China].
    Yang J; Yan H; Feng LZ; Yu HJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):1000-1006. PubMed ID: 31607045
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cost-effective analysis of seasonal influenza vaccine in elderly Chinese population].
    Chen C; Liu GE; Wang MJ; Gao TF; Jia HP; Yang H; Feng LZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):993-999. PubMed ID: 31607044
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
    JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Repeated Influenza Immunization on Respiratory Illness in Children With Preexisting Medical Conditions.
    de Hoog MLA; Venekamp RP; Damoiseaux RAMJ; Schilder AGM; Sanders EAM; Smit HA; Bruijning-Verhagen PCJL
    Ann Fam Med; 2019 Jan; 17(1):7-13. PubMed ID: 30670389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
    Lugnér AK; van Boven M; de Vries R; Postma MJ; Wallinga J
    BMJ; 2012 Jul; 345():e4445. PubMed ID: 22791791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost Effectiveness of Influenza Vaccine for U.S. Children: Live Attenuated and Inactivated Influenza Vaccine.
    Shim E; Brown ST; DePasse J; Nowalk MP; Raviotta JM; Smith KJ; Zimmerman RK
    Am J Prev Med; 2016 Sep; 51(3):309-17. PubMed ID: 27079638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis.
    Wang Q; Jin H; Yang L; Jin H; Lin L
    Infect Dis Poverty; 2023 Oct; 12(1):92. PubMed ID: 37821942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
    Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
    Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivated influenza vaccine does not reduce all cause respiratory illness in children with pre-existing medical conditions.
    de Hoog MLA; Venekamp RP; Meijer A; Sanders EAM; Bruijning-Verhagen PCJL
    Vaccine; 2020 Apr; 38(17):3397-3403. PubMed ID: 31859200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.
    Wong C; Jiang M; You JH
    PLoS One; 2016; 11(12):e0169030. PubMed ID: 28006012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States.
    de Boer PT; Crépey P; Pitman RJ; Macabeo B; Chit A; Postma MJ
    Value Health; 2016 Dec; 19(8):964-975. PubMed ID: 27987647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccination for heart failure patients: a cost-effectiveness analysis from the perspective of Chinese healthcare system.
    Zhao M; Liu F; Wang L; Chen D
    Front Public Health; 2024; 12():1348207. PubMed ID: 39185111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.